EM2503E "Optimal Blood Pressure Targets with Age: From SHEP to ESPRIT" (IM GR - 031425)
Overview
Purpose and Overview
The Systolic Blood Pressure Intervention Trial (SPRINT; ClinicalTrials.gov, NCT01206062) was stopped early because of significantly lower risk of cardiovascular disease in participants randomized to a systolic blood pressure (SBP) target of 120 mmHg (intensive) than in those randomized to 140 mmHg (standard). The cardiovascular outcome benefit was also identified in participants aged 75 and older assigned to the intensive arm—34% lower —in addition to 33% lower all-cause mortality at 3.14 years of follow-up. These beneficial outcomes held in older participants characterized as frail or with impaired gait speed. The SPRINT Memory and Cognition IN Decreased Hypertension – SPRINT MIND – study results from 2019 demonstrated a reduction in the incidence of mild cognitive impairment in the intensive group, but not in all-cause probable dementia.
Target Audience
UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.
Learning Objectives
At the conclusion of this activity, the participant should be able to:
- Be familiar with the randomized controlled trials (SHEP, HYVET, SPRINT, STEP and ESPRIT) that have informed our understanding of appropriate systolic blood pressure (SBP) targets for older adults.
- Become familiar with modifiable approaches to prevent cognitive impairment including new results from the SPRINT-MIND study.
- Recognize the potential mechanistic role for vascular stiffness and brain health
Faculty
Mark Supiano, M.D..
Professor of Internal Medicine
Division of Geriatrics
Director, Hospital Elder Life Program
University of Utah
Accreditation
Available Credit
- 1.00 AMA
Register/Take course
Price
Required Hardware/software
Activities should be run with recent versions of common browsers, including Internet Explorer, Firefox and Google Chrome